Search hospitals > Kansas > Salina

Cancer Center of Kansas - Salina

Claim this profile
Salina, Kansas 67401
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
390 reported clinical trials
2 medical researchers
Photo of Cancer Center of Kansas - Salina in SalinaPhoto of Cancer Center of Kansas - Salina in SalinaPhoto of Cancer Center of Kansas - Salina in Salina

Summary

Cancer Center of Kansas - Salina is a medical facility located in Salina, Kansas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Cancer Center of Kansas - Salina is involved with conducting 390 clinical trials across 448 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.

Area of expertise

1Cancer
Global Leader
Cancer Center of Kansas - Salina has run 86 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Cancer Center of Kansas - Salina has run 82 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive

Top PIs

Clinical Trials running at Cancer Center of Kansas - Salina

Breast Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Lung Cancer
Bladder Cancer
Renal Cell Carcinoma
Follicular Lymphoma
Cancer
Colorectal Cancer
Squamous Cell Carcinoma
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cancer Center of Kansas - Salina?
Cancer Center of Kansas - Salina is a medical facility located in Salina, Kansas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Cancer Center of Kansas - Salina is involved with conducting 390 clinical trials across 448 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.
Where is Cancer Center of Kansas - Salina located?
The Cancer Center of Kansas in Salina is situated at 600 S Santa Fe Ave, Salina, KS 67401, USA, nestled on the south side of Santa Fe Ave, between 6th and 7th Streets. Access is convenient via the Crawford St exit from I-135, followed by an eastward turn onto Crawford St and a left onto Santa Fe Ave.
Who should I call to ask about financial aid or insurance network?
**Cancer Center of Kansas - Salina Financial Assistance:** - For insurance inquiries and financial assistance, contact the main clinic at **(785) 823-1521**. - Salina Regional Health Center's Patient Financial Services Department is available for hospital bill assistance at **(785) 452-6299** or **(800) 272-8790**. - For urgent care financial screening appointments, reach out to Salina Family Healthcare Center at **785-825-7251**.
What insurance does Cancer Center of Kansas - Salina accept?
The Cancer Center of Kansas - Salina accepts a wide range of insurance plans, including but not limited to Aetna Health Plans, Amerigroup, Anthem, Blue Cross & Blue Shield, Cigna Health Care, Coventry Health Care, Humana, Medicare, United Healthcare, and Workers Compensation. It is crucial to verify your insurance coverage with the center prior to your appointment due to possible variations in policies and coverage.
What awards or recognition has Cancer Center of Kansas - Salina received?
The Cancer Center of Kansas - Salina, located in Salina, Kansas, is a distinguished member of the University of Kansas Cancer Center, boasting an NCI Comprehensive Designation for its leadership in cancer research and treatment. It has been honored as the Favorite Hospital for Cancer Care in Wichita, Kansas, for the years 2016 and 2018. Additionally, it received the 2016 Employer of the Year award from CLASS LTD.